Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6602735.pdf
Reference21 articles.
1. Anonymous (1998) Polychemotherapy for early breast cancer: an overview of randomized trials. Early Breast Cancer Collaborative Group. Lancet 352: 930–942
2. Boiesen P, Bendahl PO, Anagnostaki L, Domanski H, Holm E, Idvall I, Johansson S, Ljungberg O, Ringberg A, Ostberg G, Ferno M (2000) Histologic grading in breast cancer – reproducibility between seven pathologic departments. South Sweden Breast Cancer Group. Acta Oncol 39(1): 41–45
3. Bukholm I, Bukholm G, Nesland JM (2001) Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer 93: 283–287
4. Crown J, Dieras V, Kaufmann M, von Minckwitz G, Kaye S, Leonard R, Marty M, Misset J, Osterwalder B, Piccart M (2002) Chemotherapy for metastatic breast cancer – report of a European expert panel. Lancet Oncol 3(12): 719–727
5. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of the histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 19: 403–410
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mitochondrial NME6 Influences Basic Cellular Processes in Tumor Cells In Vitro;International Journal of Molecular Sciences;2024-09-04
2. Anticancer Effect by Combined Treatment of Artemisia annua L. Polyphenols and Docetaxel in DU145 Prostate Cancer Cells and HCT116 Colorectal Cancer Cells;Current Issues in Molecular Biology;2024-02-19
3. Leukemia inhibitory factor shortens primary cilia by upregulating C‐C motif chemokine 2 in human neural stem/progenitor cells;Genes to Cells;2023-10-14
4. Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer;Acta Pharmaceutica Sinica B;2023-10
5. PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer;Cancer Research;2023-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3